Suppr超能文献

肝纤维化不同阶段 HCC 患者肝切除术后安全标准残肝体积。

Safe standard remnant liver volume after hepatectomy in HCC patients in different stages of hepatic fibrosis.

机构信息

Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, No. 71 Hedi Road, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.

Department of Radiology, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.

出版信息

BMC Surg. 2021 Jan 23;21(1):57. doi: 10.1186/s12893-021-01065-x.

Abstract

BACKGROUND

To determine the standard remnant liver volume (SRLV) threshold to avoid postoperative hepatic insufficiency inpatients in different stages of hepatic fibrosis who undergo right hemi-hepatectomy.

METHODS

Data for 85 patients at our single medical center were analysed prospectively to examine whether the following factors differed significantly between those who experienced postoperative hepatic insufficiency and those who did not: height, prothrombin time, remnant liver volume, SRLV or hepatic fibrosis stage.

RESULTS

Logistic regression showed SRLV and hepatic fibrosis stage to be independent risk factors for postoperative hepatic insufficiency. The threshold SRLV for predicting insufficiency was 203.2 ml/m across all patients [area under receiver operating characteristic curve (AUC) 0.778, sensitivity 66.67%, specificity 83.64%, p<0.0001), 193.8 ml/m for patients with severe hepatic fibrosis (AUC 0.938, sensitivity 91.30%, specificity 85.71%, p<0.0001), and 224.3 ml/m for patients with cirrhosis (AUC 0.888, sensitivity 100%, specificity 64.29%, p<0.0001).

CONCLUSIONS

Right hemi-hepatectomy may be safer in Chinese patients when the standard remnant liver volume is more than 203.2 ml/m in the absence of hepatic fibrosis or cirrhosis, 193.8 ml/m in the presence of severe hepatic fibrosis or 224.3 ml/m in the presence of cirrhosis.

摘要

背景

确定标准残肝体积(SRLV)阈值,以避免不同肝纤维化阶段的接受右半肝切除术的患者发生术后肝衰竭。

方法

前瞻性分析我院单中心 85 例患者的数据,以检验术后发生肝衰竭与未发生肝衰竭的患者之间以下因素是否存在显著差异:身高、凝血酶原时间、残肝体积、SRLV 或肝纤维化分期。

结果

Logistic 回归显示 SRLV 和肝纤维化分期是术后肝衰竭的独立危险因素。预测不全的 SRLV 阈值为所有患者的 203.2ml/m(受试者工作特征曲线下面积(AUC)为 0.778,敏感性为 66.67%,特异性为 83.64%,p<0.0001)、重度肝纤维化患者为 193.8ml/m(AUC 为 0.938,敏感性为 91.30%,特异性为 85.71%,p<0.0001)、肝硬化患者为 224.3ml/m(AUC 为 0.888,敏感性为 100%,特异性为 64.29%,p<0.0001)。

结论

在无肝纤维化或肝硬化的情况下,SRLV 超过 203.2ml/m,在重度肝纤维化或肝硬化的情况下,SRLV 超过 193.8ml/m 和 224.3ml/m 时,右半肝切除术可能对中国患者更安全。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6936/7825235/f411cd38accb/12893_2021_1065_Fig1_HTML.jpg

相似文献

5
Assessing Hepatic Fibrosis Using 2-D Shear Wave Elastography in Patients with Liver Tumors: A Prospective Single-Center Study.
Ultrasound Med Biol. 2017 Nov;43(11):2522-2529. doi: 10.1016/j.ultrasmedbio.2017.07.003. Epub 2017 Aug 12.
6
Value of MR elastography for the preoperative estimation of liver regeneration capacity in patients with hepatocellular carcinoma.
J Magn Reson Imaging. 2017 Jun;45(6):1627-1636. doi: 10.1002/jmri.25517. Epub 2016 Nov 16.
8
The critical value of remnant liver volume-to-body weight ratio to estimate posthepatectomy liver failure in cirrhotic patients.
J Surg Res. 2014 May 15;188(2):489-95. doi: 10.1016/j.jss.2014.01.023. Epub 2014 Jan 24.
9
A new scoring system for assessment of liver function after successful hepatectomy in patients with hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int. 2011 Jun;10(3):265-9. doi: 10.1016/s1499-3872(11)60044-1.
10
Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
World J Gastroenterol. 2020 Mar 21;26(11):1208-1220. doi: 10.3748/wjg.v26.i11.1208.

本文引用的文献

2
Hepatocellular Carcinoma: Surgical Management and Evolving Therapies.
Cancer Treat Res. 2016;168:165-83. doi: 10.1007/978-3-319-34244-3_8.
4
Dynamic Evaluation of Liver Volume and Function in Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy.
J Gastrointest Surg. 2017 Jun;21(6):967-974. doi: 10.1007/s11605-017-3389-y. Epub 2017 Mar 10.
5
6
Hepatosplenic volumetric assessment at MDCT for staging liver fibrosis.
Eur Radiol. 2017 Jul;27(7):3060-3068. doi: 10.1007/s00330-016-4648-0. Epub 2016 Nov 17.
7
Hepatocellular carcinoma: From diagnosis to treatment.
Surg Oncol. 2016 Jun;25(2):74-85. doi: 10.1016/j.suronc.2016.03.002. Epub 2016 Mar 5.
8
The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review.
Eur J Surg Oncol. 2017 Jan;43(1):32-41. doi: 10.1016/j.ejso.2016.05.026. Epub 2016 Jun 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验